SciBase Holding AB (publ) (SCIB.ST) Stock Analysis & Winston Score

SciBase is a Swedish medical device company that makes a skin scanner called Nevisense. The device helps dermatologists and doctors decide whether a suspicious mole or skin lesion might be melanoma, which is the deadliest form of skin cancer. It works by sending a small electrical signal into the skin and measuring how the cells respond, a technology called electrical impedance spectroscopy. SciBase earns money by selling the Nevisense device to clinics and then charging for single-use test electrodes each time a patient is scanned, creating a recurring consumables revenue stream. The company operates mainly in Europe and has been expanding into the United States, which is a much larger market for dermatology devices. SciBase is a small, early-stage company that is spending significantly more than it earns, as shown by its deeply negative operating margin, so its main risk is running out of cash before it can grow its customer base large enough to reach profitability.